Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: Relevance to hepatocarcinogenesis

Cancer Letters

Volumn 148, Issue 1, 2000, Pages 49-57

  Chen, Shenren ^a,b   Fazle Akbar, S M ^a   Tanimoto, Kenji ^a   Ninomiya, Tsuneyuki ^a   Iuchi, Hideto ^a   Michitaka, Kojiro ^a   Horiike, Norio ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b The Second University Hospital   (China)

Author keywords

CD83; Dendritic cells; Hepatocellular carcinoma; Interdigitating cells; Liver cirrhosis; S100 protein

Indexed keywords

CD83 ANTIGEN;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL COUNT; CELL INFILTRATION; CELL MATURATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL;

ANTIGENS, CD; CARCINOMA, HEPATOCELLULAR; CELL COUNT; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; S100 PROTEINS;

EID: 0033989932     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00312-2     Document Type: Article

References (24)

1. Chisari F.V., Ferrari C. Hepatitis B virus immunopathology. Springer Semin. Immunopathol. 17:1991;261-281.
2. Nakamoto Y., Guidotti L.G., Kuhlen C.V., Fowler P., Chisari F.V. Immune pathogenesis of hepatocellular carcinoma. J. Exp. Med. 188:1998;341-350.
3. Akbar S.M.F., Kajino K., Tanimoto T., Yamamura K.-I., Onji M., Hino O. Unique features of dendritic cells in IFN-γ transgenic mice: relevance to cancer development and therapeutic implications. Biochem. Biophys. Res. Commun. 259:1999;294-299.
4. Akbar S.M.F., Onji M., Inaba K., Yamamura K., Ohta Y. Low responsiveness of hepatitis B virus transgenic mice in antibody response to T-cell-dependent antigen:defect in antigen-presenting activity of dendritic cells. Immunology. 78:1993;468-475.
5. Kurose K., Akbar S.M.F., Yamamoto K., Onji M. Production of antibody to hepatitis B virus surface antigen (anti-HBs) by murine hepatitis B virus carriers; neonatal tolerance versus antigen presentation by dendritic cells. Immunology. 92:1997;494-500.
6. Hiasa Y., Horiike N., Akbar S.M.F., Saito I., Miyamura T., Matsuura Y., Onji M. Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes. Biochem. Biophys. Res. Commun. 249:1998;90-96.
7. Akbar S.M.F., Inaba K., Onji M. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-γ: abrogation of immune response defect to a T-cell-depenedent antigen. Immunology. 87:1996;519-527.
8. Akbar S.M.F., Kajino K., Tanimoto,K T. Kurose. T. Masumoto, K. Michitaka, N. Horiike, M. Onji, Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J. Hepatol. 26:1997;131-137.
9. Akbar S.M.F., Onji M. Hepatitis B virus (HBV) transngenic mice as an investigative tool to study immunopathology during HBV infection. Int. J. Exp. Pathol. 79:1998;279-291.
10. Akabr S.M.F., Horiike N., Onji M. Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a muirne hepatitis B virus carrier. Immunology. 96:1999;98-108.
11. Akbar S.M.F., Abe M., Masumoto T., Horiike N., Onji M. Mechanism of action of vaccine therapy in murine hepatitis B virus carrier: vaccine induced activation of antigen presenting dendritic cells. J. Hepatol. 30:1999;755-764.
12. Ninomiya T., Akbar S.M.F., Masumoto T., Onji M. Dendritic cells with immature phenotype and defective function in peripheral blood from patients with hepatocellular carcinoma. J. Hepatol. 31:1999;323-331.
13. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296.
14. Hart D.N.J. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 90:1997;3245-3287.
15. Zhou L.-J., Tedder T.F. Human dendritic cells selectively express CD83, a member of immunoglobulin superfamily. J. Immunol. 95:1995;3821-3835.
16. Tanimoto K., Akbar S.M.F., Michitaka K., Onji M. Immunohistochemical localization of antigen presenting cells in liver from patients with primary biliary cirrhosis: highly restricted distribution of CD83-positive activated dendritic cells. Pathol. Res. Prac. 195:1999;157-162.
17. Demeretis A.J., Sever C., Kakizoe S., Oguma S., Stazl T.E., Jaffe R. protein-positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis. Am. J. Pathol. 134:1989;741-747.
18. Ishigami S., Aikou T., Natsugoe S., Hokita S., Iwashige H., Tokushige M., Sonoda S. Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology. 55:1998;65-69.
19. Gabrilovich D.I., Corak J., Ciernik I.F., Kavanaugh D., Carbone D.P. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3:1997;483-490.
20. Enk A.H., Jonuleit H., Saloga J., Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int. J. Cancer. 73:1997;309-316.
21. Thurnher M., Radmayr C., Ramoner R., Ebner S., Bock G., Klocker H., Romani N., Bartsch G. Human renal-cell carcinoma tissue contains dendritic cells. Int. J. Cancer. 67:1996;1-7.
22. Troy A., Davidson P., Atkinson C., Hart D.N.J. Phenotype characterisation of the dendritic cell infiltrate in prostrate cancer. J. Urol. 160:1998;214-219.
23. Troy A.J., Summers K.L., Davidson P.J.T., Atkinson C.J., Hart D.N.J. Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin. Cancer Res. 4:1998;585-593.
24. Labeur M.S., Roters B., Pers B., Mehling A., Luger T.A., Schwarz T., Grabbe S. Generation tumor immunity by bone marrow-derived dendritic cells correlates with the dendritic cell maturation stage. J. Immunol. 162:1999;168-175.